Azerbaijan imported $382.45 million of pharmaceutical products in January-September 2026. Chapter 30 accounted for 2.87% of total import value, according to customs data.
Purchases and exports
Exports in the category totalled $2.08 million, leaving an import-export gap of $380.36 million. These are customs values, rather than pharmacy turnover or patient spending.
| Indicator | Pharmaceutical products, US$ million |
|---|---|
| Imports | 382.45 |
| Exports | 2.08 |
Interpreting the figures
The value measure combines different products within the pharmaceutical chapter. Changes can reflect quantities, prices and the composition of shipments. Without a matching-period comparison and further detail, it is not evidence that medicines became more expensive or consumption increased.
The next research question
Measuring the import share of the domestic market requires data on local production, inventories and consumption. The customs report provides a starting point, but cannot establish that share on its own.